A carregar...
Ibrutinib in PCNSL: The Curious Cases of Clinical Responses and Aspergillosis
In this issue of Cancer Cell, Lionakis et al. demonstrate that the combination of temozolomide, etoposide, doxorubicin, dexamethasone, rituximab, and the Bruton tyrosine kinase (BTK) inhibitor ibrutinib induced frequent responses in patients with primary central nervous system lymphoma but was assoc...
Na minha lista:
| Publicado no: | Cancer Cell |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572136/ https://ncbi.nlm.nih.gov/pubmed/28552326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2017.05.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|